PURPOSE: To assess the value of thoracic CT in the management of @entity1 with severe @entity5492 . @entity1 AND METHODS: Between January 1997 and January 2001, 62 @entity1 were investigated for severe @entity5492 (>300 ml/24H). The protocol, performed before angiography and @entity887 , included bronchial fiberoptic examination (BFE) followed by thoracic spiral CT-angiography. Data recorded at CT and BFE were the presence and location of @entity548 , the etiology of @entity5492 and the therapeutic modality. RESULTS: Nine @entity1 with life-threatening @entity5492 directly underwent bronchial @entity887 . CT was available in the 53 remaining @entity1 . No abnormality was found in 4 @entity1 . CT assessed the presence (n=49) and the location (n=38) of the @entity548 . The etiology was determined in 49 @entity1 . BFE was feasible in 38/53 @entity1 . BFE assessed the presence (n=38) and location (n=15) of the @entity548 . The etiology was determined in 12 cases of @entity5 . The available findings of CT and BFE for the presence and the location of the @entity548 were concordant. Comparing fiberoptic examination and thoracic CT, the percentages of localized bleedings (39% and 72%) and demonstrated etiologies (32% and 92%), were significantly different (p<0,005 and p<0.0001 respectively). CONCLUSION: Although retrospective and limited by the small number of cases, our study provides arguments to perform thoracic CT before bronchial fiberoptic examination for the management of severe @entity5492 .

[Value of thoracic CT in the management of severe XXXX ].

@entity1 :: ('9606', 'Species') :: ['patients', 'PATIENTS'] @entity548 :: ('MESH:D006470', 'Disease') :: ['bleeding'] @entity5 :: ('MESH:D009369', 'Disease') :: ['bronchial tumour'] @entity887 :: ('MESH:D004617', 'Disease') :: ['embolization'] @entity5492 :: ('MESH:D006469', 'Disease') :: ['hemoptysis']
@entity5492 :: (MESH:D006469,Disease) :: ['hemoptysis']
